-
6-N-cyclohexyl-2-N-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine
-
ChemBase ID:
4991
-
Molecular Formular:
C21H27N7O
-
Molecular Mass:
393.48538
-
Monoisotopic Mass:
393.22770852
-
SMILES and InChIs
SMILES:
C1CCCCC1Nc1nc(nc2c1nc[nH]2)Nc1ccc(cc1)N1CCOCC1
Canonical SMILES:
C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2c1nc[nH]2
InChI:
InChI=1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27)
InChIKey:
ZFLJHSQHILSNCM-UHFFFAOYSA-N
-
Cite this record
CBID:4991 http://www.chembase.cn/molecule-4991.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
6-N-cyclohexyl-2-N-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine
|
6-N-cyclohexyl-2-N-[4-(morpholin-4-yl)phenyl]-7H-purine-2,6-diamine
|
N6-cyclohexyl-N2-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine
|
|
|
IUPAC Traditional name
|
6-N-cyclohexyl-2-N-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine
|
reversine
|
N6-cyclohexyl-N2-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine
|
|
|
Synonyms
|
N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine
|
Reversine
|
2-(4-Morpholinoanilino)-6-cyclohexylaminopurine
|
Reversine
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
9.709121
|
H Acceptors
|
7
|
H Donor
|
3
|
LogD (pH = 5.5)
|
3.5777729
|
LogD (pH = 7.4)
|
3.5762944
|
Log P
|
3.578217
|
Molar Refractivity
|
115.0422 cm3
|
Polarizability
|
42.85332 Å3
|
Polar Surface Area
|
90.99 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
Log P
|
4.39
|
LOG S
|
-4.04
|
Solubility (Water)
|
3.55e-02 g/l
|
DETAILS
DETAILS
DrugBank
Wikipedia
Sigma Aldrich
Sigma Aldrich -
R3904
|
Biochem/physiol Actions Reversine is a potent, selective human A3 adenosine receptor antagonist with a Ki value of 0.66 μM. Synthetic substituted purine implicated in cellular regeneration; induces differentiated myogenic-lineage-committed cells to become multipotent mesenchymal progenitor cells. |
PATENTS
PATENTS
PubChem Patent
Google Patent